Homebuilder Confidence Nudges Remains but Faces Slower Demand
The March NAHB/Wells Fargo HMI shows homebuilder confidence nudges remains at 38, signaling a tepid market as incenti...
Worst Drawdown Dividend Aristocrats Etf
Examine the worst drawdowns for Dividend Aristocrats ETF and extract lessons to strengthen risk management in your portfolio.
9,644 articles
4,300%, Biggest Reason Carvana Investors Missed
Carvana’s stock run looked extraordinary, up 4,300% in three years. But the strongest buy signal wasn’t the hype—it w...
Moment Misstep: Justin Timberlake’s Financial Wake-Up Call
A quiet road, a moment of confusion, and a spotlight on money. This piece translates a high-profile misstep into acti...
How Covid Turned America Against Science, and What Comes Next
The pandemic reshaped Americans' trust in science and altered how households save, spend, and invest. This report out...
Bitcoin, Ethereum Slip Trump as Iran War Talks Loom
When headlines hit geopolitics, crypto markets react fast. This piece explains why bitcoin and ethereum slip in respo...
Barry Diller Takes Says on CNN: A Reality Check Today
When a seasoned media veteran weighs in on CNN, it’s more than a rumor. This article translates that talk into action...
Sirius Holdings Rallied April: YouTube Deal Sparks Rally
A single month brought a sharp rally for Sirius XM as two big catalysts emerged: a new YouTube partnership expanding ...
Wall Street Sees Recession Risk Fading in 2026, but 2027 Warns
Markets push higher on resilient earnings and a sturdy job market, with recession risk receding for 2026. Yet traders...
Why Brazil Fund Opened Million in MELI Despite Steep Stock Drop
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
Nexgel (NXGL) 2026 Earnings Outlook for Investors Today
Nexgel's Q1 2026 earnings reveal the early trajectory of the year. This analysis breaks down the numbers, explains th...
Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Goldman Sachs Lifts Enphase Target, Solar Trade Rebounds
Goldman Sachs raises Enphase Energy's price target to 57 and maintains a Buy rating, highlighting a nascent rebound i...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status